Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study
Ivan Molodtsov, Evgenii Kegeles, A.N. Mitin, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e1-e9
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
Shona C. Moore, Barbara Kronsteiner, Stephanie Longet, et al.
Med (2023) Vol. 4, Iss. 3, pp. 191-215.e9
Open Access | Times Cited: 35
MHC Class II Presentation in Autoimmunity
Irina A. Ishina, Maria Yu. Zakharova, Inna N. Kurbatskaia, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 314-314
Open Access | Times Cited: 34
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity
Kathryn Bowman, Daniel Stein, Sally Shin, et al.
mBio (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 30
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity
Daichao Wu, Grigory A. Efimov, A. V. Bogolyubova, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 103035-103035
Open Access | Times Cited: 13
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
Síle A. Johnson, Eloise Phillips, Sandra Adele, et al.
Clinical & Experimental Immunology (2023) Vol. 212, Iss. 3, pp. 249-261
Open Access | Times Cited: 13
Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273
Samuel M. Ailsworth, Behnam Keshavarz, Nathan E. Richards, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 1, pp. 67-73
Open Access | Times Cited: 18
Clonal structure and the specificity of vaccine-induced T cell response to SARS-CoV-2 Spike protein
Saveliy A. Sheetikov, Alexandra Khmelevskaya, Ksenia V. Zornikova, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Genetically engineered CD80–pMHC-harboring extracellular vesicles for antigen-specific CD4+ T-cell engagement
Irina A. Ishina, Inna N. Kurbatskaia, Azad E. Mamedov, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 11
Open Access | Times Cited: 2
Monitoring Temporal Changes in SARS-CoV-2 Spike Antibody Levels and Variant-Specific Risk for Infection, Dominican Republic, March 2021–August 2022
Eric J. Nilles, Michael de St. Aubin, Devan Dumas, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 4, pp. 723-733
Open Access | Times Cited: 7
Architecture of the SARS-CoV-2-specific T cell repertoire
Ksenia V. Zornikova, Saveliy A. Sheetikov, Alexander Yu Rusinov, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia
Jolene Yin Ling Fu, Muhammad Harith Pukhari, Maria Kahar Bador, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 844-844
Open Access | Times Cited: 7
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study
Isabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 7
Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?
David Baker, Amy MacDougall, Angray S. Kang, et al.
Clinical & Experimental Immunology (2021) Vol. 207, Iss. 3, pp. 263-271
Open Access | Times Cited: 17
Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response
Ksenia V. Zornikova, Alexandra Khmelevskaya, Savely A. Sheetikov, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 11
Study of the Effects of Several SARS-CoV-2 Structural Proteins on Antiviral Immunity
Rong Yue, Fengyuan Zeng, Danjing Ma, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 524-524
Open Access | Times Cited: 5
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study
Tobias Moser, Ciara K. O’Sullivan, Ferdinand Otto, et al.
Therapeutic Advances in Neurological Disorders (2022) Vol. 15, pp. 175628642210920-175628642210920
Open Access | Times Cited: 9
Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients
Takaaki Konuma, Megumi Hamatani-Asakura, Etsuko Nagai, et al.
International Journal of Hematology (2024) Vol. 120, Iss. 2, pp. 229-240
Open Access | Times Cited: 1
SARS-CoV-2 Antibody Kinetics in Unvaccinated Hospitalized Children With COVID-19
Dimitra Dimopoulou, Marietta Charakida, Antonios Marmarinos, et al.
The Pediatric Infectious Disease Journal (2024) Vol. 43, Iss. 6, pp. 536-542
Closed Access | Times Cited: 1
Evolution of long-term vaccine induced and hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study
Shona C. Moore, Barbara Kronsteiner, Stephanie Longet, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
CD4+ and CD8+ T cell and antibody correlates of protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study
Isabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8+T cells
Olivia Lie-Andersen, Mie Linder Hübbe, Krishanthi Subramaniam, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Association between severe acute respiratory syndrome coronavirus 2 antibody status and reinfection: A case-control study nested in a Colorado-based prospective cohort study
Ingrid A. Binswanger, Komal J. Narwaney, Jennifer C. Barrow, et al.
Preventive Medicine Reports (2023) Vol. 37, pp. 102530-102530
Open Access | Times Cited: 2
Features of Highly Homologous T-Cell Receptor Repertoire in the Immune Response to Mutations in Immunogenic Epitopes
Ksenia V. Zornikova, Dmitry V. Dianov, Nataliia O Ivanova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12591-12591
Open Access
Integrated SARS-CoV-2 serological and virological screening across an acute fever surveillance platform to monitor temporal changes in anti-spike antibody levels and risk of infection during sequential waves of variant transmission — Dominican Republic, March 2021 to August 2022
Eric J. Nilles, Michael de St. Aubin, Devan Dumas, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top